With 25% of the pharmaceutical market worldwide going through some form of T&C, you are far from alone. We expect, in both developed and emerging countries that trend to not only continue, but increase. Consequently, the importance for Life Sciences companies to build a succesful tendering and contracting governance globally increases as well.